# Award #75N93026D00009

Multi-Year IDV Contract for In Vitro Antimicrobial Research with Duke University

**Buyer:** National Institutes of Health

**Award Amount:** $2,500.00
**Ceiling:** $2,500.00

**Awarded:** September 30, 2026
**Period of Performance:** Sep 30, 2026 - Sep 29, 2036

**Identifier:** 75N93026D00009
**NAICS:** 541714

This award represents an indefinite delivery vehicle (IDV) contract with Duke University, a leading educational and research institution. The contract focuses on conducting in vitro assessments of antimicrobial activity, an essential area in combating infectious diseases and advancing medical research. This multi-year agreement facilitates ongoing scientific studies to evaluate the efficacy of antimicrobial agents, thereby supporting public health initiatives and medical advancements. The scope primarily includes laboratory-based experimental services related to antimicrobial testing. The contract appears to have been competitively awarded to ensure access to top-tier research capabilities. Key milestones include an extended performance timeline spanning a decade, highlighting the contract's long-term significance for sustained antimicrobial research efforts.

### Description

IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)

[View original record](https://www.usaspending.gov/award/CONT_IDV_75N93026D00009_7529)